INTERNATIONAL PATENT: DEXCOM, INC. FILES APPLICATION FOR "SYSTEMS AND METHODS FOR PROVIDING THERAPY MANAGEMENT GUIDANCE TO PATIENTS TO OPTIMIZE GLP-1 THERAPY EFFECTIVENESS"

GENEVA, Oct. 20 -- DEXCOM, INC. (6340 Sequence DriveSan Diego, California 92121) filed a patent application (PCT/US2025/023973) for "SYSTEMS AND METHODS FOR PROVIDING THERAPY MANAGEMENT GUIDANCE TO PATIENTS TO OPTIMIZE GLP-1 THERAPY EFFECTIVENESS" on Apr 09, 2025. With publication no. WO/2025/217339, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JOHNSON, Matthew L. (c/o Dexcom, Inc.6340 Sequence DriveSan Diego, California 92121), AN, Qi (c/o Dexcom, Inc.6340 Sequence DriveSan Diego, California 92121), BARTLETT, Rush (c/...